Literature DB >> 21133731

Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.

Francesco Forconi1, Emanuele Cencini, Anna Sicuranza, Elisa Sozzi, Francesco Lauria.   

Abstract

The B cell receptor (BCR) is the functional distinguishing unit that defines any B cell. Immunoglobulin gene (IG) status is preserved in the neoplastic B cell clone and can provide an indicator of the maturation stage reached by the B cell prior to transformation. In hairy cell leukemia (HCL), several pieces of data from IG analysis provide clear hints regarding the cell of origin and the ongoing selective interactions of the tumor BCR with environmental stimuli. HCLs have variable levels of IG somatic mutations, and continue somatic mutations at low levels as well as IG class switching after transformation. More recent data also show the occurrence of selective events in the light chain of the BCR, suggesting a dominant role for IG status in the pathogenesis of HCL. Moreover, it has recently emerged that an unmutated status of the HCL IG can be associated with failure to respond to cladribine, genetic abnormalities indicative of poor outcome, and aggressive disease. These observations suggest that IG analysis may have biological and prognostic relevance in HCL and merits further characterization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21133731     DOI: 10.3109/10428194.2010.530362

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

Review 1.  Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

Authors:  John C Allen; Fatima Talab; Joseph R Slupsky
Journal:  Int J Hematol Oncol       Date:  2016-05-26

Review 2.  B-cell receptor signaling as a driver of lymphoma development and evolution.

Authors:  Carsten U Niemann; Adrian Wiestner
Journal:  Semin Cancer Biol       Date:  2013-09-20       Impact factor: 15.707

3.  The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.

Authors:  Mariela Sivina; Robert J Kreitman; Evgeny Arons; Farhad Ravandi; Jan A Burger
Journal:  Br J Haematol       Date:  2014-04-02       Impact factor: 6.998

4.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037

5.  Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.

Authors:  Edouard Cornet; Alain Delmer; Pierre Feugier; Francine Garnache-Ottou; David Ghez; Véronique Leblond; Vincent Levy; Frédéric Maloisel; Daniel Re; Jean-Marc Zini; Xavier Troussard
Journal:  Ann Hematol       Date:  2014-07-05       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.